Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
Neubauer A, Wiesmann T, Vogelmeier CF, Mack E, Skevaki C, Gaik C, Keller C, Figiel J, Sohlbach K, Rolfes C, Renz H, Wulf H, Burchert A.
Neubauer A, et al. Among authors: gaik c.
Leukemia. 2020 Aug;34(8):2276-2278. doi: 10.1038/s41375-020-0907-9. Epub 2020 Jun 17.
Leukemia. 2020.
PMID: 32555296
Free PMC article.
No abstract available.